Highest-materiality recent filing
Director Bilge Ogut resigns after GBL reduces Concentrix stake below nomination threshold
Bilge Ogut resigned from Concentrix Board effective April 29, 2026.
Concentrix stockholders approve 3.7M share increase to 2020 equity plan
Amendment to 2020 Stock Incentive Plan adds 3,700,000 shares, approved at March 25, 2026 Annual Meeting.
Concentrix Q1 revenue up 5.4% but GAAP EPS drops 68% to $0.33, margins shrink
Revenue $2,500.4M (+5.4% YoY); operating income $118.6M (-29.8%); GAAP EPS $0.33 (-68.3%).
Concentrix expands AR securitization facility to $750M, extends to March 2028
Commitment increased from $700M to $750M under receivables securitization facility.
Concentrix issues $600M 6.5% senior notes due 2029, redeems $600M of 6.65% notes due 2026
Issued $600M aggregate principal of 6.500% Senior Notes due March 1, 2029 in a registered public offering.
Concentrix prices $600M of 6.500% senior notes due 2029; will redeem $600M of existing 6.650% notes
Issued $600M principal of 6.500% Senior Notes due 2029; priced Feb 12, 2026.
Concentrix reports Q4 GAAP loss of $23.85/sh on $1.5B goodwill impairment; FY rev +2.2%
Q4 revenue $2,552.9M (+4.3% YoY); FY revenue $9,825.8M (+2.2% YoY).
Concentrix Q3 revenue above guidance; raises full-year growth outlook, increases dividend
Revenue $2,483M (+4.0% YoY), above guidance; constant-currency growth 2.6%.
Revenue $2,417M (+1.5% YoY) beat guidance; full-year growth outlook raised.
Director Olivier Duha resigns from Concentrix board for personal reasons
Olivier Duha notified the Board of his resignation effective June 3, 2025.
On June 3, 2025, Olivier Duha notified the Board of Directors (the “Board”) of Concentrix Corporation (the “Company”) of his decision to resign from the Board, including any committees thereof, effective immediately.
Max materiality 0.80 · Median 0.53 · Most common event earnings